UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000015212 |
|---|---|
| Receipt number | R000017181 |
| Scientific Title | Oocyte cryopreservation for fertility-preservation of young woman in cancer and immune disease. |
| Date of disclosure of the study information | 2014/09/20 |
| Last modified on | 2020/09/24 09:05:14 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Oocyte cryopreservation for fertility-preservation of young woman in cancer and immune disease.
Acronym
Oocyte cryopreservation for fertility-preservation
Scientific Title
Oocyte cryopreservation for fertility-preservation of young woman in cancer and immune disease.
Scientific Title:Acronym
Oocyte cryopreservation for fertility-preservation
Region
| Japan |
Condition
Condition
Cancer patient including hematological malignancy, autoimmune disease such as SLE, premature ovarian failure
Classification by specialty
| Medicine in general | Gastroenterology | Hepato-biliary-pancreatic medicine |
| Pneumology | Endocrinology and Metabolism | Hematology and clinical oncology |
| Nephrology | Clinical immunology | Gastrointestinal surgery |
| Hepato-biliary-pancreatic surgery | Chest surgery | Endocrine surgery |
| Breast surgery | Obstetrics and Gynecology | Pediatrics |
| Orthopedics | Urology | Neurosurgery |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
Verification of the effectiveness and safety in oocyte cryopreservation as a clinical study for a fertility-preservation
Basic objectives2
Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Evaluation for a prospective advantage and disadvantage (including complications with the ovarian stimulation)
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Medicine |
Interventions/Control_1
All the members receive the same medical intervention
Period (routinely oocyte pick up)
Medicational quantity (different among individuals)
The number of times (1-2 times of oocyte pick up)
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| 42 | years-old | >= |
Gender
Female
Key inclusion criteria
Survival is anticipated for a long term
After the menarche, younger than 42 years
Key exclusion criteria
An agreement is not obtained
Patient (including age 43 years old or more) who are judged to be inappropriate of this study
The patient whom the start of therapy delays for this study
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | MASAKI |
| Middle name | |
| Last name | MANDAI |
Organization
Graduate school of medicine, Kyoto University
Division name
Department of obstetrics and gynecology
Zip code
606-8507
Address
Kawaharacho 54, Sho-goin, Sakyo-ku, Kyoto
TEL
075-751-3267
mandai@kuhp.kyoto-u.ac.jp
Public contact
Name of contact person
| 1st name | AKIHITO |
| Middle name | |
| Last name | HORIE |
Organization
Graduate school of medicine, Kyoto University
Division name
Department of obstetrics and gynecology
Zip code
606-8507
Address
Kawaharacho 54, Sho-goin, Sakyo-ku, Kyoto
TEL
075-751-3269
Homepage URL
a_horie@kuhp.kyoto-u.ac.jp
Sponsor or person
Institute
Graduate school of medicine, Kyoto University
Department of obstetrics and gynecology
Institute
Department
Personal name
Funding Source
Organization
Graduate school of medicine, Kyoto University
Department of obstetrics and gynecology
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Kyoto University Hospital / department of Ob / Gy
Address
Kawaharacho 54, Sho-goin, Sakyo-ku, Kyoto
Tel
075-751-3111
kuobgyn@kuhp.kyoto-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
京都大学附属病院
Other administrative information
Date of disclosure of the study information
| 2014 | Year | 09 | Month | 20 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2014 | Year | 09 | Month | 20 | Day |
Date of IRB
| 2014 | Year | 11 | Month | 12 | Day |
Anticipated trial start date
| 2014 | Year | 11 | Month | 12 | Day |
Last follow-up date
| 2024 | Year | 11 | Month | 11 | Day |
Date of closure to data entry
| 2024 | Year | 11 | Month | 11 | Day |
Date trial data considered complete
| 2024 | Year | 11 | Month | 11 | Day |
Date analysis concluded
| 2024 | Year | 11 | Month | 11 | Day |
Other
Other related information
Management information
Registered date
| 2014 | Year | 09 | Month | 20 | Day |
Last modified on
| 2020 | Year | 09 | Month | 24 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017181
| Research Plan | |
|---|---|
| Registered date | File name |
| Research case data specifications | |
|---|---|
| Registered date | File name |
| Research case data | |
|---|---|
| Registered date | File name |
